Both in Surgical Instruments
Boston Scientific vs West Pharmaceutical Services
Over the past year BSX returned −57.4% and WST returned +47.5%; their daily moves had a correlation of 0.05.
BSX −57.4% WST +47.5%Growth of $1, one year, split-adjusted
| Metric | BSX | WST |
|---|---|---|
| Price | $41.98 | $412.62 |
| Market cap | $60.84B | $28.74B |
| Today | −1.66% | −0.97% |
| 1 month | −2.9% | +13.0% |
| 6 months | −25.7% | +37.2% |
| Year to date | −56.0% | +50.0% |
| 1 year | −58.1% | +44.9% |
| Revenue growth (YoY) | +7.5% | +8.7% |
| Gross margin | 70.7% | 39.7% |
| Net margin | 16.7% | 24.5% |
| P/E (TTM) | 16.6× | 45.0× |
| Price / sales | 2.9× | 8.5× |
| Net cash | -$12.09B | $261.2M |
| Dividend yield | — | 0.21% |
| Volatility (60d) | 34.7% | 20.3% |
| Short % of float | 2.8% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).